Victoza 18 mg/3 mL (6 mg/mL) pre-filled pen Images
Generic Name: liraglutide
This medication has been identified as Victoza 18 mg/3 mL (6 mg/mL) pre-filled pen. It is supplied by Novo Nordisk.
Victoza is used in the treatment of Cardiovascular Risk Reduction; Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Victoza: Risk cannot be ruled out during pregnancy. Saxenda: Not for use in pregnancy. Victoza 18 mg/3 mL (6 mg/mL) pre-filled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Victoza
- Generic Name
- liraglutide
- Strength
- 18 mg/3 mL (6 mg/mL) pre-filled pen
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- Pregnancy Category
- C - Risk cannot be ruled out - Victoza, X - Not for use in pregnancy - Saxenda
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4060
More about Victoza (liraglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (766)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.